Michael A. Weiss, M.D., Ph.D. is a Distinguished Professor at Indiana University and Precision Health Initiative Professor of Biochemistry at the IU School of Medicine. In his academic career Dr. Weiss has long investigated the structure and function of insulin, a body of work recognized in 2020 by the JDRF’s Gerold and Kayla Grodsky Basic Research Scientist Award. He is a graduate of Harvard College, the Harvard-MIT Program in Health Sciences & Technology (HST) and M.D.-Ph.D. Program at Harvard Medical School. With clinical training at the Brigham & Women’s Hospital, he is Board Certified in Internal Medicine. Holding > 20 patents in insulin technologies, Dr. Weiss is a founder and Chief Innovation Officer of Thermalin, Inc. Following Ph.D. research under Prof. Martin Karplus (Harvard Chemistry) and clinical training, Dr. Weiss joined the Endocrine Unit at the Massachusetts General Hospital (1988-1994). He was a member of the junior faculty of the Department of Biological Chemistry & Molecular Pharmacology at Harvard Medical School (1988-1994), Professor at the University of Chicago (1994-1999), and Cowan-Blum Professor, Distinguished Research Professor and Department Chair at the CWRU School of Medicine (1999-2017). Dr. Weiss is a past chair of the NIDDK Board of Scientific Counselors at the National Institutes of Health. He is a member of American Society for Clinical Investigation (ASCI) and American Association of Physicians (AAP). A Presidential Scholar in 1975 (Ohio) and former member of the White House
Commission on Presidential Scholars. Dr. Weiss is or has been a member of several non-profit Boards, including the Cleveland Museum of Natural History, the Diabetes Association of Greater Cleveland, the Summer Science Foundation International and the United States Presidential Scholars Foundation.